![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Ben Venue Consent Decree Could Be Signal on Hospira, Analyst Says
Ben Venue Consent Decree Could Be Signal on Hospira, Analyst Says
January 25, 2013
Boehringer Ingelheim subsidiary Ben Venue Laboratories has signed a consent decree to resolve a history of GMP slipups. The decree would let it continue making some essential drugs while a third party assesses its facilities — a provision analysts say could open the door to a similar decree for Hospira.
Drug Industry Daily
Drug Industry Daily
Upcoming Events
-
21Oct